BridgeBio Oncology Therapeutics, Inc. (BBOT): 4 filed Jun 18, 2026

Form type
4
Filing date
Jun 18, 2026
Accession number
0001193125-26-276048
Filer
BridgeBio Oncology Therapeutics, Inc. (CIK 1869105)